Xiaodong Cheng
from Houston, TX
Xiaodong Cheng Phones & Addresses
- 1700B Sunset Blvd, Houston, TX 77005 • (404)3213421
- 1700 Sunset Blvd, Houston, TX 77005
- 2425 Holly Hall St, Houston, TX 77054 • (713)8055201
Work
-
Company:University of texas medical branchAug 1999
-
Position:Professor
Education
-
Degree:Postdoctoral
-
School / High School:University of California, San Diego1995 to 1999
-
Specialities:Biochemistry
Skills
Cell Biology • Molecular Biology • Biochemistry • Genetics • Animal Models • Genomics • Drug Discovery • Pharmacology • Biophysics • High Throughput Screening • Proteomics • Fluorescence Spectroscopy
Industries
Research
Medicine Doctors
Xiaodong Cheng
view sourceSpecialties:
Anesthesiology
Us Patents
-
Use Of Tumor Susceptibilty Gene 101 (Tsg 101) As A Prognostic And Diagnostic Marker
view source -
US Patent:20070243547, Oct 18, 2007
-
Filed:Feb 13, 2007
-
Appl. No.:11/706109
-
Inventors:Xiaodong Cheng - League City TX, US
Fang Mel - League City TX, US
Travis Young - Galveston TX, US
Jinsong Liu - Houston TX, US -
International Classification:A61K 31/7088
A61P 35/00
C12Q 1/68 -
US Classification:435006000, 514044000
-
Abstract:The present invention discloses the link between oncogenic Ras and TSG101 and the negative effect of TSG101 on the expression of p21 in ovarian cancer. The present also discloses the use of TSG101 as a prognostic, diagnostic marker and a potential therapeutic target in cancer, especially ovarian cancer.
-
Methods And Compositions For Treating Chronic Pain
view source -
US Patent:20160263088, Sep 15, 2016
-
Filed:Mar 10, 2016
-
Appl. No.:15/066416
-
Inventors:Xiaodong Cheng - Houston TX, US
Fang Mei - Houston TX, US
Annemieke Kavelaars - Houston TX, US
Cobi J. Heijnen - Houston TX, US -
Assignee:The Board of Regents of the University of Texas System - Austin TX
-
International Classification:A61K 31/42
-
Abstract:Certain embodiments are directed to methods of treating pain, e.g., chronic or neuropathic pain, comprising administering an effective amount of an EPAC inhibitor.
-
Methods Of Treating Rickettsia Using Exchange Proteins Directly Activated By Camp (Epacs) Inhibitors
view source -
US Patent:20140348853, Nov 27, 2014
-
Filed:Aug 8, 2014
-
Appl. No.:14/455325
-
Inventors:Bin Gong - League City TX, US
Xiaodong Cheng - League City TX, US
David Walker - Galveston TX, US
Fang Mei - League City TX, US -
Assignee:The Board of Regents of the University of Texas System - Austin TX
-
International Classification:A61K 31/42
A61K 45/06 -
US Classification:4241531, 514378, 4241841
-
Abstract:Embodiments of the invention are directed to compounds that inhibit an activity of EPAC proteins and methods of using the same.
Resumes
Professor At The University Of Texas Health Science Center At Houston
view sourceLocation:
1932 Woodbury St, Houston, TX 77030
Industry:
Research
Work:
University of Texas Medical Branch since Aug 1999
Professor
Professor
Education:
University of California, San Diego 1995 - 1999
Postdoctoral, Biochemistry The University of Texas Medical Branch at Galveston 1990 - 1994
Peking University 1981 - 1985
BS, Biology
Postdoctoral, Biochemistry The University of Texas Medical Branch at Galveston 1990 - 1994
Peking University 1981 - 1985
BS, Biology
Skills:
Cell Biology
Molecular Biology
Biochemistry
Genetics
Animal Models
Genomics
Drug Discovery
Pharmacology
Biophysics
High Throughput Screening
Proteomics
Fluorescence Spectroscopy
Molecular Biology
Biochemistry
Genetics
Animal Models
Genomics
Drug Discovery
Pharmacology
Biophysics
High Throughput Screening
Proteomics
Fluorescence Spectroscopy
Youtube
Googleplus
Xiaodong Cheng
Xiaodong Cheng
Xiaodong Cheng
Education:
Hunan University
Get Report for Xiaodong Cheng from Houston, TX